Direct oral anticoagulants for venous thromboembolism in hemodialysis: reassurance, not yet certainty
Kidney Research and Clinical Practice · 30.10.2026
DOI: 10.23876/j.krcp.26.388 ↗Kurz gefasst
Editorial in der Zeitschrift Kidney Research and Clinical Practice, online erschienen am 30.10.2026. Verfasst von Hanjin Park und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea. heetyu@yuhs.ac.
Zitieren
APA
Park, H., & Yu, H. T. (2026). Direct oral anticoagulants for venous thromboembolism in hemodialysis: reassurance, not yet certainty. Kidney Research and Clinical Practice. https://doi.org/10.23876/j.krcp.26.388
Vancouver
Park H, Yu HT. Direct oral anticoagulants for venous thromboembolism in hemodialysis: reassurance, not yet certainty. Kidney Research and Clinical Practice. 2026. doi:10.23876/j.krcp.26.388
BibTeX
@article{Park2026,
author = {Park, Hanjin and Yu, Hee Tae},
title = {Direct oral anticoagulants for venous thromboembolism in hemodialysis: reassurance, not yet certainty},
journal = {Kidney Research and Clinical Practice},
year = {2026},
doi = {10.23876/j.krcp.26.388}
}
EUVIMED